Role of c-Src Activation on Prostate Cancer Lymph Node Metastases
作者： Serk I. Park
DOI: 10.21236/ADA493721
关键词:
摘要: Abstract : This is a final report of Pre-doctoral Prostate Cancer Training Program (PCRP) for Dr. Serk In Park, Ph.D. student in the Biology, University Texas M.D. Anderson Center. PI this training grant, has completed all requirements degree earlier than originally proposed date, leading to early termination grant. includes scientific and educational accomplishments directly supported by key findings research.
researchgate.net 
sci-hub.st 参考文章(19)
Justin M. Summy, Src family kinases in tumor progression and metastasis Cancer and Metastasis Reviews. ,vol. 22, pp. 337- 358 ,(2003) , 10.1023/A:1023772912750
Jerald J. Killion, Graham Greene, Michael R. Wilson, Edilberto Ramirez, Sen Pathak, Isaiah J. Fidler, Curtis A. Pettaway, Selection of highly metastatic variants of different human prostatic carcinomas using orthotopic implantation in nude mice. Clinical Cancer Research. ,vol. 2, pp. 1627- 1636 ,(1996)
Hagop Kantarjian, Ricardo Pasquini, Nelson Hamerschlak, Philippe Rousselot, Jerzy Holowiecki, Saengsuree Jootar, Tadeusz Robak, Nina Khoroshko, Tamas Masszi, Aleksander Skotnicki, Andrzej Hellmann, Andrey Zaritsky, Anatoly Golenkov, Jerald Radich, Timothy Hughes, Athena Countouriotis, Neil Shah, Dasatinib or high-dose imatinib for chronic-phase chronic myeloid leukemia after failure of first-line imatinib: a randomized phase 2 trial. Blood. ,vol. 109, pp. 5143- 5150 ,(2007) , 10.1182/BLOOD-2006-11-056028
Timothy A. Masterson, Fernando J. Bianco, Andrew J. Vickers, Christopher J. DiBlasio, Paul A. Fearn, Farhang Rabbani, James A. Eastham, Peter T. Scardino, The association between total and positive lymph node counts, and disease progression in clinically localized prostate cancer. The Journal of Urology. ,vol. 175, pp. 1320- 1325 ,(2006) , 10.1016/S0022-5347(05)00685-3
Fernando J. Bianco, Peter T. Scardino, James A. Eastham, Radical prostatectomy: Long-term cancer control and recovery of sexual and urinary function (“trifecta”) Urology. ,vol. 66, pp. 83- 94 ,(2005) , 10.1016/J.UROLOGY.2005.06.116
Serk In Park, Jing Zhang, Kacy A. Phillips, John C. Araujo, Amer M. Najjar, Andrei Y. Volgin, Juri G. Gelovani, Sun-Jin Kim, Zhengxin Wang, Gary E. Gallick, Targeting SRC family kinases inhibits growth and lymph node metastases of prostate cancer in an orthotopic nude mouse model. Cancer Research. ,vol. 68, pp. 3323- 3333 ,(2008) , 10.1158/0008-5472.CAN-07-2997
Louis J. Lombardo, Francis Y. Lee, Ping Chen, Derek Norris, Joel C. Barrish, Kamelia Behnia, Stephen Castaneda, Lyndon A. M. Cornelius, Jagabandhu Das, Arthur M. Doweyko, Craig Fairchild, John T. Hunt, Ivan Inigo, Kathy Johnston, Amrita Kamath, David Kan, Herbert Klei, Punit Marathe, Suhong Pang, Russell Peterson, Sidney Pitt, Gary L. Schieven, Robert J. Schmidt, John Tokarski, Mei-Li Wen, John Wityak, Robert M. Borzilleri, Discovery of N-(2-chloro-6-methyl- phenyl)-2-(6-(4-(2-hydroxyethyl)- piperazin-1-yl)-2-methylpyrimidin-4- ylamino)thiazole-5-carboxamide (BMS-354825), a dual Src/Abl kinase inhibitor with potent antitumor activity in preclinical assays. Journal of Medicinal Chemistry. ,vol. 47, pp. 6658- 6661 ,(2004) , 10.1021/JM049486A
Jing Zhang, Serk In Park, Marlene C. Artime, Justin M. Summy, Ami N. Shah, Joshua A. Bomser, Andrea Dorfleutner, Daniel C. Flynn, Gary E. Gallick, AFAP-110 is overexpressed in prostate cancer and contributes to tumorigenic growth by regulating focal contacts. Journal of Clinical Investigation. ,vol. 117, pp. 2962- 2973 ,(2007) , 10.1172/JCI30710
Timothy J. Yeatman, A renaissance for SRC Nature Reviews Cancer. ,vol. 4, pp. 470- 480 ,(2004) , 10.1038/NRC1366
Axel Heidenreich, Zoltan Varga, Rolf Von Knobloch, Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: high incidence of lymph node metastasis. The Journal of Urology. ,vol. 167, pp. 1681- 1686 ,(2002) , 10.1016/S0022-5347(05)65177-4